Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Biosimilars [Design Issues]

posted by M.Vasu – India, 2011-11-24 15:01 (4091 d 12:35 ago) – Posting: # 7712
Views: 5,619

Hi,

Can any one explain regarding BE study procedure for Biosimilars (Injection) in healthy subjets?

Thanks,

VM..........

Edit: Category changed. [Helmut]

Complete thread:

BiosimilarsM.Vasu 2011-11-24 14:01 [Design Issues]
- Biosimilars Helmut 2011-11-24 14:44
  - Biosimilars M.Vasu 2011-11-28 12:33
    - Healthy subjects vs. patients Helmut 2011-11-28 12:56
    - Biosimilars drgunasakaran1 2012-02-06 13:57
  - Biosimilars Ben 2011-12-16 19:04
- Biosimilars Chiku 2012-02-03 06:43
  - Biosimilars drgunasakaran1 2012-02-10 11:33
    - Biosimilars Chiku 2012-02-10 12:03
      - Biosimilars Kumarnaidu2 2021-10-22 07:53

Admin contact
22,479 posts in 4,709 threads, 1,603 registered users;
13 visitors (0 registered, 13 guests [including 9 identified bots]).
Forum time: 03:37 CET (Europe/Vienna)

The rise of biometry in this 20^th century,
like that of geometry in the 3^rd century before Christ,
seems to mark out one of the great ages or critical periods
in the advance of the human understanding. R.A. Fisher

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz